Insightec brings Exablate to Brazil

By staff writers

February 16, 2021 -- MR-guided focused ultrasound (MRgUS) developer Insightec is expanding its presence in Latin America via a partnership with Brazilian medical equipment developer Strattner.

Insightec said it has received market approval for its Exablate 4000 (Neuro) platform from the National Health Surveillance Agency (ANVISA) in Brazil. Designed as a treatment for essential tremor and tremor-dominant Parkinson's Disease that has not responded to medications and neuropathic pain, Exablate Neuro provides MR-guided focused ultrasound to ablate tissue deep in the brain, according to the company.

Copyright © 2021

To read this and get access to all of the exclusive content on create a free account or sign-in now.

Member Sign In:
MemberID or Email Address:  
Do you have a password?
No, I want a free membership.
Yes, I have a password:  
Forgot your password?
Sign in using your social networking account:
Sign in using your social networking